Dr. Kaag is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
500 University Drive
UPC 3100
Hershey, PA 17033Phone+1 717-531-8521Fax+1 717-531-4475
Summary
- Dr. Kaag is a board certified urologist who completed a urologic oncology fellowship at Memorial Sloan-Kettering Cancer Center in 2010. His practice focuses on the surgical management of patients with complex or advanced urologic cancers. He co-leads the Genitourinary Cancer Team at the Penn State Cancer Insitute and coordinates multidisciplinary cancer care for his patients. His clinical interests include bladder cancer, locally advanced kidney cancer, penile cancer, and testicular cancer. His research focuses on understanding barriers to recovery following radical cystectomy for bladder cancer.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2007 - 2010
Penn State Milton S Hershey Medical CenterResidency, Urology, 2003 - 2007- Penn State Milton S Hershey Medical CenterInternship, Transitional Year, 2002 - 2003
Pennsylvania State University College of MedicineClass of 2002
Certifications & Licensure
PA State Medical License 2002 - 2024
NY State Medical License 2007 - 2010- American Board of Urology Urology
Clinical Trials
Publications & Presentations
PubMed
- 12 citationsIntraoperative Conversion From Partial to Radical Nephrectomy at a Single Institution From 2003 to 2008David J. Galvin, Caroline O. S. Savage, Ari Adamy, Matthew Kaag, Matthew F. O'Brien
The Journal of Urology. 2011-04-01 - 8 citationsConcurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: results from phase II stud...Monika Joshi, Leonard Tuanquin, Junjia Zhu, Vonn Walter, Todd Schell
Journal for Immunotherapy of Cancer. 2023-02-01 - 71 citationsObesity is associated with a higher risk of clear-cell renal cell carcinoma than with other histologiesWilliam T. Lowrance, R. Houston Thompson, David S. Yee, Matthew Kaag, S. Mac Hele Donat
BJU International. 2010-01-01
Journal Articles
- Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
- Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell CarcinomaBrian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology
Press Mentions
Detecting and Treating Urologic Cancers with Penn State Hershey Cancer InstituteSeptember 8th, 2015
Grant Support
- Enhancing Patient Resilience During Multimodal Therapy for Bladder CancerWells Fargo Barsumian Trust2013–2014
Professional Memberships
- Member
- Mid-Atlantic Section, AUAMember
- Urologic Oncology Research AllianceChair
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
